DOCSLIB.ORG

Legal-Graphics 8-11 COVID

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Days since first COVID-19 Events sign of virus Indonesia North Carolina 24 Pennsylvania 26 Countries Affected Wyoming Madagascar 49 Ecuador Kyrgyzstan Massachusetts India New Hamshire 25 South Carolina 32 Philippines Feb. 18, 2020 North Dakota Montserrat Zimbabwe 56 Country Name 62 Macau Nepal Illinois Ireland 31 Barbados El Salvador Washington 53 Italy Russia Georgia 28 Chile So. Africa Peru Missouri Nebraska 13 15 California Worldwide New Mexico Montana New Caledonia Papau or Coronavirus Deaths Austria Netherlands 19 24 Kansas 23 13 Gambia Mauritius Taiwan Hong Kong Malaysia Sri Lanka India UK New York 19 New Jersey 17 Tennessee 25 Minnesota Arizona Connecticut 14 Turkey Michigan Mississippi 21 Maine 20 over 2,000 Nicaragua Cape Verde >5,000 Deaths* Wisconsin 13 South Korea Vietnam Australia Cambodia UAE Spain Switzerland Pakistan Oregon 24 Florida 31 Colorado 21 Maryland 25 Kentucky 19 Utah Virginia Vermont 26 Ohio 14 South Dakota Delaware 13 Idaho 12 Montenegro Bermuda or East Timor China France Thailand Japan US Singapore Canada Germany Finland Sweden Belgium Egypt Iran Israel Iraq Brazil Mexico Rhode Island 27 Texas 29 Nevada 27 Hawaii 17 Indiana 17 Oklahoma 15 Iowa Lousiana 13 St. Vincent Arkansas Alaska 15 Alabama 22 St. Maarten Djibouti West Virginia 6 # Number of countries Uganda reporting on same day France ? (symbol is linked to 6 11 5 4 8 3 7 20 9 page with more detail) 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 US States Affected Nov. 17, 2019 Dec. 1, 2019 Dec. 10, 2019 Dec. 27, 2019 Dec. 30, 2019 Jan. 5, 2020 Jan. 14, 2020 Jan. 16, 2020 Jan. 24, 2020 Jan. 28, 2020 Feb. 4, 2020 Feb. 11, 2020 Feb. 15, 2020 Feb. 24, 2020 Feb. 27, 2020 Mar. 2, 2020 Mar. 7, 2020 Mar. 9, 2020 Mar. 10, 2020 Mar. 11, 2020 Mar. 14, 2020 Mar. 16, 2020 Mar. 18, 2020 State Name China’s first China’s first case Wei Guixian, a Amirouche Hammar, Dr. Ai Fen posts 5 days after being First evidence that Japan confirms first France declares China places 16 Federal Act goes WHO names novel First known case US stock market WHO designates Georgia’s first two 103-year-old A US cruise ship 114 days after WHO characterizes US bans travel US volunteer Venice canals or known case of has no reported 57-year-old Chinese a 42-year-old an image of a notified by virus could be case of infection three more cities on lockdown in effect that coronavirus disease in Africa - Egypt plummets - Dow 2020 as the Year of cases were a couple Chinese woman with passengers China’s first COVID-19 as for non-Americans is injected with are clear enough recovers in 6 days and crew testing confirmed case, a pandemic from 26 European experimental to see fish >1,000 Deaths* # coronavirus; now link to Wuhan woman, falls ill French fishmonger diagnostic report Chinese officials, transmitted from coronavirus confirmed cases -an estimated protects qualified "COVID-19” Jones worst day the Nurse who had just France’s first Seafood Market while working is the first showing that WHO issues a human to human of COVID-19 50 million people persons engaged in in 2 years returned from Italy after being positive for virus people begin countries COVID-19 vaccine possible cases at the confirmed case the patient had a press release (Thailand case) facilitating virus Both had mild diagnosed with docks in Oakland to return to work Number of days after Feb. 12, 2020 Feb. 28, 2020 Mar. 12, 2020 Mar. 18, 2020 first confirmed case (see page 158) Huanan Seafood in France and pneumonia Jan. 20, 2020 countermeasures symptoms and have COVID-19 virus California Jan. 25, 2020 Jan. 29, 2020 Mar. 15, 2020 Mar. 16, 2020 that a shelter-in-place Wholesale Market in the EU infection caused by from liability Feb. 25, 2020 since recovered Federal Act which order was enacted US reports its 23 days after More than 20 Mar. 10, 2020 NBA suspends a SARS-like Jan. 7, 2020 Jan. 14, 2020 New Orleans requires certain first confirmed case Canada reports Finland reports South Korea’s Brazil confirms first vaccines are in all games and the US adds the UK coronavirus first known case first known case first confirmed case; cases of development Italy extends rest of professional and Ireland to the restaurant sues employers to Link to Dec. 16, 2019 Outbreak in China WHO officials -a male in his 30s Feb. 6, 2020 Source emergency insurer for pay sick leave is identified as give conflicting in Washington state case, their numbers COVID-19 have globally, sports and NCAA travel restrictions Guixian is admitted measures business to employees Dec. 30, 2019 a new coronavirus signals about US has its first begin to spike now been confirmed and several follow and suspend, to the hospital. Feb. 1, 2020 nationwide interruption losses affected by Signs of Virus whether there is known death - on every continent therapeutics are in postpone, or A doctor there COVID-19, Dr. Li Wenliang human-to-human Coronavirus death in California except Antarctica clinical trials cancel seasons Key Events describes her illness goes into effect shares Jan. 9, 2020 transmission in the Philippines and tournaments Mar. 16, 2020 as “ruthless” and Dr. Fen’s post Good News! is the first fatality tells her several First known death outside of China Feb. 7, 2020 Feb. 25, 2020 All Las Vegas, NV other people from from virus: A Legal Matters Jan. 15, 2020 casinos close the same market Dec. 31, 2019 61-year-old Chinese 40 days after first CDC warns US of COVID-19 spread; Oklahoma Events had already come male who First rapid sounding the alarm, Chinese Health Feb. 2, 2020 “prepare for the in with similar frequented Wuhan diagnostic test is Dr. Li Wenliang dies Mar. 17, 2020 officials inform WHO expectation that Economic News symptoms Seafood Market introduced by a 36 countries of coronavirus about a cluster this might be bad.” South Korea’s team from Germany have imposed of 41 patients travel restrictions case have dropped with a mysterious sharply. What they pneumonia are doing right www.legalgraphics.net Somaliland St. Pierre Miquelon Apr. 9, 2020 Apr. 24, 2020 May 14, 2020 May 27, 2020 June 7, 2020 June 18, 2020 June 28, 2020 St. Eustatius Mozambique British Virgin Islands S. Sudan Worldwide Worldwide Worldwide Worldwide Worldwide Worldwide Worldwide Sierra Leon Aland Islands Syria Turks and Caicos Laos Guinea-Bissau W. Sahara Abkhazia Coronavirus Deaths Coronavirus Deaths Coronavirus Deaths Coronavirus Deaths Coronavirus Deaths Coronavirus Deaths Coronavirus Deaths Burundi over 100,000 over 200,000 over 300,000 over 350,000 over 400,000 over 450,000 over 500,000 Libya Artsakh Eritrea Grenada Myanmar St. Kitts and Nevis Falkand Is Tajikistan Transnistria Dominica Belize Easter Island Mali Anguilla Botswana São Tomé and Príncipe Artsakh Yemen Saba Bonaire Comoros South Ossetia Lesptho Malawi Abkhazia 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 Mar. 23, 2020 Mar. 25, 2020 Mar. 30, 2020 Apr. 3, 2020 Apr. 9, 2020 Apr. 14, 2020 Apr. 19, 2020 Apr. 24, 2020 Apr. 28, 2020 May 4, 2020 May 7, 2020 May 10, 2020 May 15, 2020 May 19, 2020 May 23, 2020 May 25, 2020 May 28, 2020 May 30, 2020 June 2, 2020 June 7, 2020 June 9, 2020 June 11, 2020 June 15, 2020 June 17, 2020 June 20, 2020 June 24, 2020 June 27, 2020 July 1, 2020 China administers COVID-19 Treatment 102-year-old woman CDC advises India sees FDA approves Sweden reports Some states end A UK developed Scientists discover Travel from NYC How Georgia is It’s back to work You can’t get Start of Memorial Global deaths due Feel depressed? Anger floods cities Russia cases 100 days after Asymptomatic Pandemic Why a second Oklahoma bending Ups and downs of Virus antibodies Younger people How the states its first clinical trials and Prevention: in Italy recovers all Americans improvement first saliva test to their strategy is (SIP) orders on vaccine is showing antibody which seeded wave doing since their for a lot of states; COVID-19 Day Weekend; to various You are not alone across the US now over 420K; New York City’s spread “appears statistics shutdown might the curve in the COVID-19 cases - may fade in as are straining the compare on the of vaccines 66 programs use after 20 days to wear cloth in air quality detect COVID-19 proving effective or before Apr 30 promise prevents infection of US Outbreaks Apr 24 reopening see more details a second time? how different causes including deaths over 5K first confirmed to be rare” be worse than wrong direction see interactive little as 2 months healthcare systems testing and cases to volunteers three different in hospital masks in public parts of the US COVID-19 case, reopening the first – and how WHO charts May 28, 2020 May 30, 2020 June 12, 2020 approaches May 7, 2020 are handling it begins to prevent it Apr.
Recommended publications
  • Business Quarterly (Summer 2017)

    Business Quarterly (Summer 2017)

    Summer 2017 Regional Development With AEB updates on: #investment climate in Russia, #localisation in the Russian regions, #discovering Krasnodar Region, #St. Petersburg investment legislation, #AEB news, #Committee activities, #member news, and #new members. | Introduction AEB Business Quarterly | Summer 2017 Dear readers, Welcome to the summer issue of the AEB Business Quarterly! The Association of European Businesses represents the interests of foreign investors in Russia and sup- ports foreign companies operating on the Russian market. Far more than 50% of foreign direct invest- ments originate from the European Union, so the country’s investment attractiveness is of vital impor- tance for the AEB. The AEB is focused on engaging with the Russian regions. We have two Regional Committees: the North-Western and the Southern ones with the offices in Saint Petersburg and Krasnodar correspondingly. They actively cooperate with the regional and local authorities and take part in the work of the investment councils of the governments of the Krasnodar and Leningrad regions, and the city of St. Petersburg. On 1 June 2017, the AEB signed an Agreement on Cooperation with Leningrad region within the framework of the St.Petersburg International Forum. The AEB regularly holds presentations of the investment potential of the regions in Moscow. Thus, recently we have hosted several events on the investment potential of the Altai and Sakhalin regions, the North Caucasus and the Chuvash Republic. The Association regularly organises business missions to the Russian regions and meetings with the regional governors, enabling companies to get acquainted with the investment opportunities of the given region as well as the terms of co- operation and development.
  • International Symposium on Novel Ideas in Science and Ethics Of

    International Symposium on Novel Ideas in Science and Ethics Of

    I N T E R N A T I O N A L S Y M P O S I U M O N N O V E L I D E A S I N S C I E N C E A N D E T H I C S O F V A C C I N E S A G A I N S T C O V I D - 1 9 P A N D E M I C 30 JULY 2020 DEPARTMENT OF HEALTH RESEARCH MINISTRY OF HEALTH AND FAMILY WELFARE, GOVERNMENT OF INDIA International Symposium on Novel ideas in Science and Ethics of Vaccines against COVID-19 pandemic Date: 30th July 2020 / 4:30 pm – 6:45 pm IST (A fully online, multi-country program) Moderated / Facilitated by Chris Anderson, Curator, TED talks Follow Live at - https://icmrvaccines.impcom.in/ Timing (IST) Session Speakers / Discussants Prof K VijayRaghavan Principal Scientific Advisor to Govt. of India Dr Renu Swarup Secretary, Dept of Biotechnology, Government of India 16.30 – 16:36 Welcome and Introductory Statement Prof Heidi Larson Director of The Vaccine Confidence Project (VCP); Professor, London School of Hygiene and Tropical Medicine, UK Prof Adam Kamradt-Scott Director, Global Health Security Network, Associate Professor, University of Sydney, Australia 16:36 – 16:41 Confronting the pandemic Dr Anthony S Fauci Director, National Institute of Allergy and Infectious Diseases, USA 16:42 – 16:43 A short Video Timely & Safe – Towards a Covid-19 Prof Peter Piot vaccine (Leadership remarks)- Role of Director, London School of Hygiene and Tropical Medicine, UK vaccines in ending epidemics Prof Stanley Plotkin 16:45 – 17:06 Introduced by: Mr JVR Prasada Rao Author of Plotkin’s Vaccines, Emeritus Professor, University of Pennsylvania, USA National Task Force COVID-19 member and Former Secretary for Health, Govt.
  • San Bernardino County Waiting, for Now, to Expand Stage 2 Coronavirus Reopening – Redlands Daily Facts

    San Bernardino County Waiting, for Now, to Expand Stage 2 Coronavirus Reopening – Redlands Daily Facts

    San Bernardino County waiting, for now, to expand Stage 2 coronavirus reopening – Redlands Daily Facts LOCAL NEWS • News San Bernardino County waiting, for now, to expand Stage 2 coronavirus reopening By SANDRA EMERSON | [email protected] | PUBLISHED: May 19, 2020 at 4:58 p.m. | UPDATED: May 19, 2020 at 10:37 p.m. While San Bernardino County supervisors are eager for restaurants and churches to resume operations after weeks of novel coronavirus-related closures and restrictions, they’re waiting to see how the county’s data pairs with new state guidelines on reopening various sectors. After a lively debate Tuesday, May 19, about the risks associated with reopening ahead of the state, the supervisors agreed to hear more from county staff before expanding the second of the state’s four-phase plan to reopen businesses. Supervisors agreed to meet at 4 p.m. Thursday, May 21, to further discuss the matter. “Our small businesses have sat and waited,” Supervisor Robert Lovingood said. “They’ve waited patiently as long as they can. They cannot suffer this economic suppression any longer.” Lovingood and Supervisor Dawn Rowe supported moving forward with the county’s recovery plan, which assesses the risk of the virus’ spread at businesses and offers guidelines for reopening safely. However, the item was not on the agenda, so the board agreed to schedule a special meeting. https://www.redlandsdailyfacts.com/2020/05/19/san-bernardino-county-waiting-for-now-to-expand-stage-2-coronavirus-reopening/[5/20/2020 8:18:00 AM] San Bernardino County waiting, for now, to expand Stage 2 coronavirus reopening – Redlands Daily Facts TOP ARTICLES 1/5 S A By .st0{fill:#FFFFFF;}.st1{fill:#0099FF;} M READ MORE Thousands evacuated as river dams break in central “This is a serious thing we have to do in the right way,” Chairman Curt Hagman said.
  • Covid-19 Vaccines Are Coming

    Covid-19 Vaccines Are Coming

    COVID-19 VACCINES ARE COMING. ARE WE READY? Etienne Grass – November 2020 On November 9, companies BioNTech and Pfizer 240 COVID vaccines are currently being developed announced the eagerly awaited preliminary results globally, according to the regular census carried out of their phase 3 clinical trial for a COVID vaccine by the World Health Organization. Of these, the project. While it is unusual for this type of result to WHO asserts 45 are in clinical trials2, although only be published before the trial is finalized, the rolling 35 according to the New York Times3. review procedure sanctioned by regulatory bodies to speed up the assessment of new drugs has The WHO says that 10 products are already tested enabled this transparency.1 in phase 3 , a figure that rises to 11 according to the New York Times, which includes the recent progress If the results have come as a positive surprise, it is of an Indian product in its assessment 4. mainly due to their high level of efficacy. The Food and Drug Administration (FDA) had indicated that it Within these phase 3 trials, four products are being would be ready to authorize a vaccine with more tested in China5 and one in Russia6. We do not have than 50% effectiveness. The first figures available the same level of information on them as on are much higher, at 90%. vaccines developed in the United States and Europe. For several weeks now, the head of the "Operation Technological platforms of current projects Warp Speed" program, Moncef Slaoui, who has been piloting American federal activities in support of Five products have in common that they are vaccine production since May, had been telling the integrated into the American (Operation Warp New York Times to be "confident that there will Speed-OWS), British and European partnerships7.
  • Plasma Proteomics of COVID-19 Associated Cardiovascular Complications: Implications for Pathophysiology and Therapeutics

    Plasma Proteomics of COVID-19 Associated Cardiovascular Complications: Implications for Pathophysiology and Therapeutics

    Plasma Proteomics of COVID-19 Associated Cardiovascular Complications: Implications for Pathophysiology and Therapeutics Jason Roh Harvard Medical School Robert Kitchen Harvard Medical School https://orcid.org/0000-0003-1443-8559 J Sawalla Guseh Massachusetts General Hospital Jenna McNeill Massachusetts General Hospital Malika Aid Beth Israel Deaconess Medical Center BIDMC Amanda Martinot Tufts University https://orcid.org/0000-0001-6237-6191 Andy Yu Massachusetts General Hospital Colin Platt Massachusetts General Hospital James Rhee Massachusetts General Hospital Brittany Weber Brigham and Women's Hospital Lena Trager Massachusetts General Hospital Margaret Hastings Massachusetts General Hospital Sarah Ducat Tufts University https://orcid.org/0000-0002-5285-7642 Peng Xia Massachusetts General Hospital Claire Castro Massachusetts General Hospital Bjarni Atlason Page 1/26 Massachusetts General Hospital Timothy Churchill Massachusetts General Hospital Marcelo Di Carli Brigham and Women's Hospital Patrick Ellinor The Broad Institute of MIT and Harvard https://orcid.org/0000-0002-2067-0533 Dan Barouch Beth Israel Deaconess Medical Center https://orcid.org/0000-0001-5127-4659 Jennifer Ho Massachusetts General Hospital Anthony Rosenzweig ( [email protected] ) Massachusetts General Hospital Article Keywords: COVID-19, cardiovascular complications, disease severity, mortality Posted Date: June 8th, 2021 DOI: https://doi.org/10.21203/rs.3.rs-539712/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 2/26 Abstract Cardiovascular complications are common in COVID-19 and strongly associated with disease severity and mortality. However, the mechanisms driving cardiac injury and failure in COVID-19 are largely unknown. We performed plasma proteomics on 80 COVID-19 patients and controls, grouped according to disease severity and cardiac involvement.
  • Herd Immunity Is an Important—And Often Misunderstood—Public Health Phenomenon

    Herd Immunity Is an Important—And Often Misunderstood—Public Health Phenomenon

    CORE CONCEPTS Herd immunity is an important—and often misunderstood—public health phenomenon CORE CONCEPTS Amy McDermott, Science Writer In December, Anthony Fauci predicted that 70 to 85% Since the earliest months of the COVID-19 pan- of the United States population may need to be demic, “herd immunity” has become shorthand for vaccinated to achieve “herd immunity” against SARS- the day when enough people are immune to the virus CoV-2 (1). Yet he was very careful to qualify his com- that social distancing can end and healthcare systems ments. “We need to have some humility here,” he said are no longer overwhelmed. People have been clam- ’ in a New York Times interview, “We really don’t know oring to know when we ll get there. But even as Fauci — what the real number is.” (2) Fauci, director of the and other officials continue to try to calculate and communicate—when it might happen, they have to National Institute of Allergy and Infectious Diseases, contend with both public misunderstanding of the admitted that the number could be as high as 90%. term and scientific disagreement over what it means. But even a year into the pandemic, there were too The public health concept of herd immunity has a many uncertainties to offer a definite threshold. And more nuanced definition than its popular usage, which with vaccine hesitancy widespread, he worried that is one reason why predicting when we’ll achieve it re- setting the bar at such a high number would cause mains difficult. In theory, estimating the threshold to the public to despair of ever reaching it.
  • Affidavit from Michael Osterholm

    Affidavit from Michael Osterholm

    27-CR-20-12951 Filed in District Court State of Minnesota 1/19/2021 3:22 PM STATE OF MINNESOTA DISTRICT COURT COUNTY OF HENNEPIN FOURTH JUDICIAL DISTRICT State of Minnesota, AFFIDAVIT OF MICHAEL T. OSTERHOLM, Ph.D., MPH Plaintiff, V. Derek Michael Chauvin, Court File No.2 27-CR-20-12646 J. Alexander Kueng, Court File No.2 27-CR—20-12953 Thomas Kiernan Lane, Court File No.2 27-CR-20-12951 Tou Thao, Court File No.: 27-CR-20-12949 Defendants. TO: The Honorable Peter Cahill, Judge of District Court, and counsel for Defendants; Eric J. Nelson, Halberg Criminal Defense, 7900 Xerxes Avenue South, Suite 1700, Bloomington, MN 55431; Robert Paule, 920 Second Avenue South, Suite 975, Minneapolis, MN 55402; Earl Gray, 1st Bank Building, 332 Minnesota Street, Suite W1610, St. Paul, MN 55101; Thomas Plunkett, U.S. Bank Center, 101 East Fifth Street, Suite 1500, St. Paul, MN 55101. MICHAEL T. OSTERHOLM, being duly sworn under oath, states as follows: Background and Qualifications 1. My name is Michael Osterholm, and I am an epidemiologist and the director of the Center for Infectious Disease Research and Policy at the University of Minnesota. 2. I am currently a Regents Professor, McKnight Presidential Endowed Chair in Public Health, Distinguished Teaching Professor in the Division of Environmental Health Sciences in the School of Public Health, a professor in the Technological Leadership Institute, and an adjunct professor in the Medical School, all at the University of Minnesota. 27-CR-20-12951 Filed in District Court State of Minnesota 1/19/2021 3:22 PM On November 9, 2020, President-elect Joseph Biden named me to be one of the sixteen members of his Coronavirus Advisory Board.
  • Arxiv:2003.13670V4 [Cs.CY] 3 Apr 2020 IV Program

    Arxiv:2003.13670V4 [Cs.CY] 3 Apr 2020 IV Program

    Anonymous Collocation Discovery: Harnessing Privacy to Tame the Coronavirus∗ Ran Canetti† Ari Trachtenberg‡ Mayank Varia§ Boston University April 7, 2020 Abstract Successful containment of the Coronavirus pandemic rests on the ability to quickly and reliably identify those who have been in close proximity to a contagious individual. Existing tools for doing so rely on the collection of exact location information of individuals over lengthy time periods, and combining this information with other personal information. This unprecedented encroachment on individual privacy at national scales has created an outcry and risks rejection of these tools. We propose an alternative: an extremely simple scheme for providing fine-grained and timely alerts to users who have been in the close vicinity of an infected individual. Crucially, this is done while preserving the anonymity of all individuals, and without collecting or storing any personal information or location history. Our approach is based on using short-range communication mechanisms, like Bluetooth, that are available in all modern cell phones. It can be deployed with very little infrastructure, and incurs a relatively low false-positive rate compared to other collocation methods. We also describe a number of extensions and tradeoffs. We believe that the privacy guarantees provided by the scheme will encourage quick and broad voluntary adoption. When combined with sufficient testing capacity and existing best practices from healthcare professionals, we hope that this may significantly reduce the infection rate. To avoid confusion, we stress that this work does not propose any direct medical treatment. arXiv:2003.13670v4 [cs.CY] 3 Apr 2020 Rather, it proposes a way to pool together information from the community in order to help (a) direct medical personnel in how to best allocate and use testing resources, and (b) direct individuals as to when to get tested and self-quarantine.
  • State of the Civil Society in the Russian Federation

    State of the Civil Society in the Russian Federation

    STATE OF THE CIVIL SOCIETY IN THE RUSSIAN FEDERATION REPORT FOR 2019 www.oprf.ru STATE OF THE CIVIL SOCIETY IN THE RUSSIAN FEDERATION REPORT FOR 2019 UDK [324/324+338]:328.181(470+571)’’2019’’ BBK 65.9(2Рос)+66.3(2Рос)+67.400.6(2Рос) Contents Д63 INTRODUCTION 4 D63 Report on the state of civil society in the Russian Federation for 2019 — М., 1. INSTITUTIONS OF PUBLIC CONTROL AND FORMATION OF the Civic Chamber of the Russian Federation, 2019. “PEOPLE’S AGENDA” 6 ISBN 978-5-89644-136-6 Citizens’ petitions as a tool to understand the “people’s agenda” 8 Regional civic chambers as public-state dialog sites 12 Public councils: new role in the work of authorities 21 Inter-commission working group to prepare the report L.Y. Mikheeva, Civil society activists in the field of public control 27 V.A. Fadeev, M.S. Anichkin, V.I. Vinnitsky, V.V. Grib, N.A. Daikhes, N.M. Ignatenko, E.A. Istyagina-Yeliseeva, A.N. Kovalchuk, S.A. Kuznetsova, A.N. Maksimov, M.A. Pogosyan, Public Monitoring Committees (PMCs): humanitarian and social tasks 32 N.B. Pochinok, A.A. Malkevich, A.V. Razbrodin, S.I. Rybalchenko, E.V. Sutormina, Public expertise: contribution of civil society to the quality E.A. Topoleva-Soldunova, E.M. Tsunaeva, I.E. Chestin, A.V. Shipulin, I.L. Shpektor. of institutional environment 35 Local and territorial self-governments as an environment for forming The working group expresses its gratitude for taking part in the work and the civic engagement 44 materials provided to members of the Civic Chamber of the Russian Federation V.A.
  • Inland Communities of Color Receiving Vaccinations at Slower Rate, Data Shows – Press Enterprise ___

    Inland Communities of Color Receiving Vaccinations at Slower Rate, Data Shows – Press Enterprise ___

    2/4/2021 Inland communities of color receiving vaccinations at slower rate, data shows – Press Enterprise ___ NEWS •• News Inland communities of color receiving vaccinations at slower rate, data shows Victorville resident Marvin Abella, 32, receives his second vaccination shot of the Pfizer-BioNTech COVID-19 Vaccine by licensed vocational nurse Mayra Aceves at Arroyo Valley High School in San Bernardino on Thursday, Jan. 28, 2021. 500 second doses were scheduled to be given out Thursday with another 500 scheduled for Friday. (Photo by Will Lester, Inland Valley Daily Bulletin/SCNG) By DEEPA BHARATH || [email protected] || OrangeOrange CountyCounty Register PUBLISHED: February 3, 2021 at 6:42 p.m. || UPDATED:UPDATED: February 3, 2021 at 6:42 p.m. https://www.pe.com/2021/02/03/inland-communities-of-color-receiving-vaccinations-at-slower-rate-data-shows/?utm_medium=social&utm_c… 1/8 2/4/2021 Inland communities of color receiving vaccinations at slower rate, data shows – Press Enterprise Communities of color are behind when it comes to being vaccinated for the coronavirus, a disparity Inland Empire officials say they are working to address. In Riverside County, where 50% of the population is Latino, for example, only 17.9% of those who have been vaccinated are Latino while 44.9% are White, county officials said Wednesday, Feb. 3. Meanwhile, 4.1% of the total number of vaccinations administered have been given to African Americans and 10.7% toto AsianAsian Americans,Americans, whichwhich eacheach representrepresent aboutabout 6.5%6.5% ofof thethe countyʼscountyʼs population. Native American and Pacific Islander residents, who represent 0.8% and 0.3% of the population, respectively, account for 0.6% and 0.7% of thosethose vaccinated.vaccinated.
  • ASTICS-2020 BOOK of ABSTRAСTS

    ASTICS-2020 BOOK of ABSTRAСTS

    Vth INTERNATIONAL CONFERENCE “ACTUAL SCIENTIFIC & TECHNICAL ISSUES OF CHEMICAL SAFETY” ASTICS-2020 BOOK of ABSTRAСTS October 6 - 8 , 2020 Kazan, Russia Ministry of Science and Higher Education of the Russian Federation; Ministry of Industry and Trade of the Russian Federation; N.N. Semenov Federal Research Center for Chemical Physics, Russian Academy of Sciences; Federal State Unitary Enterprise “State Research Institute of Organic Chemistry and Technology”; Federal Research Center “Kazan Scientific Center of the Russian Academy of Sciences”; A.E. Arbuzov Institute of Organic and Physical Chemistry — Subdivision of FRC Kazan SC of RAS N.N. Vorozhtsov Novosibirsk Institute of Organic Chemistry SB RAS Semenov International Center of Chemical Physics Vth INTERNATIONAL CONFERENCE “ACTUAL SCIENTIFIC & TECHNICAL ISSUES OF CHEMICAL SAFETY” ASTICS-2020 BOOK of ABSTRACTS October 6 - 8 , 2020 Kazan УДК 504.054 ББК 20.18 Vth International Conference “Actual Scientific & Technical Issues of Chemical Safety” (ASTICS-2020) Kazan, October 6 - 8, 2020. Book of Abstracts eds.: Prof. Alexander V. Roshchin, PhD Elena G. Raevskaya ISBN 978-5-4465-2932-2 DOI:10.25514/CHS.2020.05.7755 Book of Conference Abstracts includes Conference Program and summaries of scientific research results and activities in the field of fundamental and interdisciplinary research of chemical safety issues and protection of human health and environment from exposure to hazardous chemical factors. The topical issues are: Chemical hazard sources. Toxic chemicals, including persistent organic pollutants, pesticides, emergency and hazardous chemical substances. Methods and tools for indication and identification of hazardous chemicals and mixtures thereof in environmental objects. Monitoring soil, air, and water status. Green technologies.
  • Literature Overview October 25, 2020. Many Thanks to Peter Reiss!

    Literature Overview October 25, 2020. Many Thanks to Peter Reiss!

    Literature Overview October 25, 2020. Many thanks to Peter Reiss! Lipsitch M, Dean N, Understanding COVID-19 efficacy. Science, October 21, 2020. https://science.sciencemag.org/content/early/2020/10/21/science.abe5938 Commentary about. COVID-19 vaccine efficacy by Marc Lipsitch and Natalie Dean Important questions that will likely remain after first vaccine trials are published and should be addressed: - First, trials are typically not powered to establish subgroup-specific efficacy, yet the performance of the vaccine in high-risk groups affects the success of a direct-protection strategy. - Second, can vaccines prevent infection or reduce contagiousness? This matters for achieving indirect protection. Treatment Toculizimab Commentary on tocilizumab studies: https://www.jwatch.org/fw117147/2020/10/20/tocilizumab-covid-19-three-studies-yield- mixed-findings?query=pfwRS&jwd=000020075418&jspc=ID Salvarani C et al, Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia - A Randomized Clinical Trial. JAMA, October 21, 2020. https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2772186 b Design - This is a prospective, open label RCT to evaluate the effect of early tocilizumab administration vs standard therapy in preventing clinical worsening in patients hospitalized with COVID-19 pneumonia in Italy. Eligibility criteria - included COVID-19 pneumonia documented by radiologic imaging, partial pressure of arterial oxygen to fraction of inspired oxygen (Pao2/Fio2) ratio between 200 and 300 mm Hg, and an inflammatory phenotype defined by fever and elevated C- reactive protein. Interventions - Patients in the experimental arm received 2 iv doses of tocilizumab. Patients in the control arm received supportive care following the protocols of each clinical center until clinical worsening and then could receive tocilizumab as a rescue therapy.